Literature DB >> 1533401

Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease.

J L Bradshaw1, J G Phillips, C Dennis, J B Mattingley, D Andrewes, E Chiu, J M Pierson, J A Bradshaw.   

Abstract

Recent research has shown that Huntington's disease (HD) causes problems in the initiation and execution of movement (akinesia, bradykinesia): information which is useful in documenting the functional progression of the disease. The present experiment used a sequential movement task to characterize such impairments. Eighteen patients diagnosed as suffering from HD, and a similar number of matched At-Risk (AR) and Normal control subjects, performed sequential button pressing tasks, under varying amounts of visual advance information. Specific dimensions of motor control were examined (hand, direction). Movement initiation and in particular movement duration were useful indicators of the functional progression of the disease, and also detected anomalies of performance in some AR individuals. Impaired motor programming was indicated by patients' difficulty in initiating movements in the absence of external visual cues, and their problems in utilizing advance information to control movement. Patients had specific deficits in initiating movements with the nonpreferred hand, and directional movement asymmetries were accentuated. The results suggest that HD causes difficulties at three discrete levels: in utilizing advance information, in the initiation and in the spatial representation of movement.

Entities:  

Mesh:

Year:  1992        PMID: 1533401     DOI: 10.1080/01688639208402822

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  13 in total

1.  Movement preparation in high-functioning autism and Asperger disorder: a serial choice reaction time task involving motor reprogramming.

Authors:  N J Rinehart; J L Bradshaw; A V Brereton; B J Tonge
Journal:  J Autism Dev Disord       Date:  2001-02

2.  Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax.

Authors:  H C Cromwell; K C Berridge
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 3.  Neurology of volition.

Authors:  Sarah M Kranick; Mark Hallett
Journal:  Exp Brain Res       Date:  2013-01-18       Impact factor: 1.972

4.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

5.  Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle.

Authors:  Elizabeth Hernández-Echeagaray; Nancy González; Angélica Ruelas; Ernesto Mendoza; Erika Rodríguez-Martínez; Rafael Antuna-Bizarro
Journal:  Neurol Sci       Date:  2010-08-24       Impact factor: 3.307

6.  Sensorimotor mapping affects movement correction deficits in early Huntington's disease.

Authors:  M Lemay; E Fimbel; A Beuter; S Chouinard; F Richer
Journal:  Exp Brain Res       Date:  2005-05-05       Impact factor: 1.972

7.  Advance information and movement sequencing in Gilles de la Tourette's syndrome.

Authors:  N Georgiou; J L Bradshaw; J G Phillips; J A Bradshaw; E Chiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

8.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 9.  Motor functions of the basal ganglia.

Authors:  J G Phillips; J L Bradshaw; R Iansek; E Chiu
Journal:  Psychol Res       Date:  1993

Review 10.  [Neuropsychiatric aspects of Huntington chorea. Presentation of 2 cases and review of the literature].

Authors:  H Tost; A Schmitt; S Brassen; C S Wendt; D F Braus
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.